How to Improve the Safe and Effective Use of Doxorubicin in Children with Cancer John N. van den Anker Commentary 28 June 2015 Pages: 1091 - 1093
Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products Sam G. RaneyThomas J. FranzMei-Ling Chen Review Article 11 June 2015 Pages: 1095 - 1106
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis David TernantTheodora Bejan-AngoulvantGilles Paintaud Review Article 28 June 2015 Pages: 1107 - 1123
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update Renli Teng Review Article Open access 11 June 2015 Pages: 1125 - 1138
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer Swantje VöllerJoachim BoosGeorg Hempel Original Research Article 30 April 2015 Pages: 1139 - 1149
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole Kim VanstraelenJohan MaertensIsabel Spriet Original Research Article 25 April 2015 Pages: 1151 - 1160
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD Simon J. C. DaviesBenoit H. MulsantRobert R. Bies Original Research Article 14 May 2015 Pages: 1161 - 1168
Prediction of Fat-Free Mass in Children Hesham Saleh Al-SallamiAilsa GouldingStephen Brent Duffull Original Research Article 05 May 2015 Pages: 1169 - 1178